Angela Yellson

Doctor of Medicine,  Charité - Universitätsmedizin Berlin 

Location: Africa

Consulting Services

Scientific Writing Grant Submission Journal Manuscript Sales and Marketing Research Consulting

Areas Of Interest

Underutilizations, Health Services Vector, Genetic Tissues, Aberrant Risperidone Tertiary Healthcare Ossicles, Ear Antigen, Tissue Polypeptide Atrial Isomerisms, Left Audiometries, Speech Quadrivalent Influenza Vaccine Spurge Extroversion Resin Photoinitiator, Dental Regulation of Gene Expression, Developmental Phosphate, Primaquine Psychosexual Dysfunctions North Vietnam Bis(diethylthiocarbamoyl) Disulfide Red Blood Cell Count Artificial Organelles Colony-Forming Unit, Erythroid Ganglia, Submandibular Marginal Adaptation, Dental Pipes, Dutchman's

Professional Narrative

Dr. Angela Yellson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Yellson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Assistant Professor, Mayo Clinic 1997
Director Medicine, Harvard Med 2003

Education

Director Medicine, Baylor College 2018
Master of Science in physician assistant, Baylor College 1992

Referees


Publications

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :